Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 12;14(6):e0008205.
doi: 10.1371/journal.pntd.0008205. eCollection 2020 Jun.

Use of pyriproxyfen in control of Aedes mosquitoes: A systematic review

Affiliations

Use of pyriproxyfen in control of Aedes mosquitoes: A systematic review

John Christian Hustedt et al. PLoS Negl Trop Dis. .

Abstract

Dengue is the most rapidly spreading arboviral disease in the world. The current lack of fully protective vaccines and clinical therapeutics creates an urgent need to identify more effective means of controlling Aedes mosquitos, principally Aedes aegypti, as the main vector of dengue. Pyriproxyfen (PPF) is an increasingly used hormone analogue that prevents juvenile Aedes mosquitoes from becoming adults and being incapable of transmitting dengue. The objectives of the review were to (1) Determine the effect of PPF on endpoints including percentage inhibition of emergence to adulthood, larval mortality, and resistance ratios; and (2) Determine the different uses, strengths, and limitations of PPF in control of Aedes. A systematic search was applied to Pubmed, EMBASE, Web of Science, LILACS, Global Health, and the Cochrane database of Systematic Reviews. Out of 1,369 records, 90 studies met the inclusion criteria. Nearly all fit in one of the following four categories 1) Efficacy of granules, 2) Auto-dissemination/horizontal transfer, 3) use of ultra-low volume thermal fogging (ULV), thermal fogging (TF), or fumigant technologies, and 4) assessing mosquito resistance. PPF granules had consistently efficacious results of 90-100% inhibition of emergence for up to 90 days. The evidence is less robust but promising regarding PPF dust for auto-dissemination and the use of PPF in ULV, TF and fumigants. Several studies also found that while mosquito populations were still susceptible to PPF, the lethal concentrations increased among temephos-resistant mosquitoes compared to reference strains. The evidence is strong that PPF does increase immature mortality and adult inhibition in settings represented in the included studies, however future research should focus on areas where there is less evidence (e.g. auto-dissemination, sprays) and new use cases for PPF. A better understanding of the biological mechanisms of cross-resistance between PPF, temephos, and other insecticides will allow control programs to make better informed decisions.

PubMed Disclaimer

Conflict of interest statement

I have read the journal's policy and the authors of this manuscript have the following competing interests: RB is also the PI on an epi study of dengue among children in western Uganda that is funded by Takeda, the maker of one of the tetravalent dengue vaccines. NA is working on the development of a field trial of Integrated Vector Management, including pyriproxyfen, against dengue.

Figures

Fig 1
Fig 1. Summary of 30 studies included investigating the effect of PPF granules.
Fig 2
Fig 2. Summary of 19 studies included investigating the effect of auto dissemination or horizontal transfer of PPF.
Fig 3
Fig 3. Summary of 15 studies included investigating the effect of PPF ultra low volume spray, thermal fogging, and fumigant technologies.
Fig 4
Fig 4. Summary of 10 studies included investigating resistance of Aedes mosquitoes to PPF.

References

    1. World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention, and control. Spec Program Res Train Trop Dis. 2009; WHO/HTM/NTD/DEN/2009.1 - PubMed
    1. Whitehorn J, Yacoub S, Anders KL, Macareo LR, Cassetti MC, Nguyen Van VC, et al. Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions. PLoS Negl Trop Dis. United States; 2014;8: e3025 10.1371/journal.pntd.0003025 - DOI - PMC - PubMed
    1. Halstead SB. Pathogenesis of dengue: Challenges to molecular biology. Science (80-). 1988; 10.1126/science.3277268 - DOI - PubMed
    1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496: 504–507. 10.1038/nature12060 - DOI - PMC - PubMed
    1. Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012; 10.1371/journal.pntd.0001760 - DOI - PMC - PubMed

Publication types